Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

Nicholas A. Marston, Shinwan Kany, Giorgio E. M. Melloni, Sean J. Jurgens, Frederick K. Kamanu, Yi-Pin Lai, Joel T. Rämö, Itamar Raz, Stephen D. Wiviott, Patrick T. Ellinor, Marc S. Sabatine, Christian T. Ruff · 2026

Read Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants by Nicholas A. Marston, Shinwan Kany, Giorgio E. M. Melloni, Sean J. Jurgens, Frederick K. Kamanu, Yi-Pin Lai, Joel T. Rämö, Itamar Raz, Stephen D. Wiviott, Patrick T. Ellinor, Marc S. Sabatine, Christian T. Ruff (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13278951.txt.

Description

Nicholas A Marston and colleagues test a diabetes drug's heart protection in people carrying cardiomyopathy gene variants, in a 2026 analysis. Genetic data came from the DECLARE-TIMI 58 trial of dapagliflozin in type 2 diabetes. Whether carriers of heart muscle disease variants gain extra benefit was unknown.

Sequencing covered 12,685 trial participants, and 121 carried a harmful variant in a high-confidence cardiomyopathy gene. Most carriers had never had heart failure before the trial. Dapagliflozin cut hospitalisation for heart failure far more sharply in carriers than in non-carriers. The absolute gain reached about thirteen percentage points in carriers. The authors propose early treatment for carriers and call for a dedicated prospective trial.

Catalog record

CREATORNicholas A. Marston, Shinwan Kany, Giorgio E. M. Melloni, Sean J. Jurgens, Frederick K. Kamanu, Yi-Pin Lai, Joel T. Rämö, Itamar Raz, Stephen D. Wiviott, Patrick T. Ellinor, Marc S. Sabatine, Christian T. Ruff
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13278951

Browse the full library · About the Tower of Babel